These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35933572)

  • 1. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic.
    Kaufman HW; Chen Z; Niles JK; Radcliff J; Fesko Y
    JCO Clin Cancer Inform; 2021 Sep; 5():1028-1033. PubMed ID: 34648367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
    Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
    Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
    Doan C; Li S; Goodwin JS
    JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database.
    Grimm LJ; Lee C; Rosenberg RD; Burleson J; Simanowith M; Fruscello T; Pelzl CE; Friedewald SM; Moy L; Zuley ML
    J Am Coll Radiol; 2022 Aug; 19(8):919-934. PubMed ID: 35690079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
    JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.
    Chen N; Cheng D; Sodipo MO; Barnard ME; DuPre NC; Tamimi RM; Warner ET
    Breast Cancer Res Treat; 2023 Nov; 202(2):335-343. PubMed ID: 37624552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
    Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
    J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tomosynthesis Impact on Breast Cancer Screening in Patients Younger Than 50 Years Old.
    Rose SL; Shisler JL
    AJR Am J Roentgenol; 2018 Jun; 210(6):1401-1404. PubMed ID: 29629810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
    Sprague BL; Nowak SA; Ahern TP; Herschorn SD; Kaufman PA; Odde C; Perry H; Sowden MM; Vacek PM; Weaver DL
    Radiol Imaging Cancer; 2024 May; 6(3):e230161. PubMed ID: 38578209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of time intervals in cancer screenings and older participants' characteristics, in a nationally representative sample.
    Razavi M; Bergerot CD; Philip EJ; Dale W
    J Geriatr Oncol; 2023 Jan; 14(1):101392. PubMed ID: 36344421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
    Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
    Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
    Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
    Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.
    Qian Z; Chen X; Cole AP; Abdollah F; Choueiri TK; Kibel AS; Lipsitz SR; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Feb; 7(1):151-154. PubMed ID: 37487814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
    Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
    JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.